APA (7th ed.) Citation

E. G. Kosolapov, F. S. Kochenkov, S. K. Zyryanov, & O. A. Gladkov. (2018). Cost-effectiveness analysis of pembrolizumab versus targeted therapies in advanced melanoma. Izdatelstvo OKI.

Chicago Style (17th ed.) Citation

E. G. Kosolapov, F. S. Kochenkov, S. K. Zyryanov, and O. A. Gladkov. Cost-effectiveness Analysis of Pembrolizumab Versus Targeted Therapies in Advanced Melanoma. Izdatelstvo OKI, 2018.

MLA (9th ed.) Citation

E. G. Kosolapov, et al. Cost-effectiveness Analysis of Pembrolizumab Versus Targeted Therapies in Advanced Melanoma. Izdatelstvo OKI, 2018.